The Biotech Industry has continued to provide investors with impressive gains in 2013. The iShares NASDAQ Biotechnology ETF (NASDAQ:IBB - News) and the SPDR S&P Biotech ETF (NYSEARCA:XBI - News) have ...
GenVec Inc. (GNVC) Achieves First Milestone in Collaboration, Eligible to Receive up to $213.6 Million on Sales GAITHERSBURG, Md., Sept. 14 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) today announced ...
GenVec, Inc. (GNVC) has been on the move lately as the stock has risen by 83.5% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but ...
The beleaguered gene therapy field hasn't exactly proven a hotbed for dealmaking, and Novartis' (NVS) decision to pony-up a little cash for GenVec's (GNVC) preclinical hearing loss program could be a ...
GAITHERSBURG, Md., June 15, 2010 /PRNewswire via COMTEX/ -- GenVec, Inc. /quotes/comstock/15*!gnvc/quotes/nls/gnvc (GNVC 0.50, -0.01, -1.67%) today announced that it ...
Shares of GenVec (NASDAQ:GNVC) soared 12% Thursday morning after the medicine and vaccine maker said it received a conditional license for a foot-and-mouth disease vaccine for use in cattle. The ...
NEW YORK (CBS.MW) - Shares of GenVec Inc. lost nearly half their value Thursday after the Food and Drug Administration put the company's TNFerade cancer drug trials on hold. The stock GNVC plunged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results